|
Medical technology maker Covidien PLC reported fourth-quarter earnings of $461 million, or 95 cents per diluted share, a rise of 2.2 percent from the $451 million, or 92 cents per diluted share reported during the same period in 2011.
more
By PBN Staff
|
|
Rhode Island life science entrepreneurs with breakthrough research they hope will conquer the marketplace have a new ally.
more
By Patrick Anderson |
|
Amgen Inc., the world’s largest biotechnology company, is developing a new anti-cholesterol medicine by 2015 that it sees as its best shot to offset reduced sales when its popular anemia drugs lose exclusivity.
more
By Ryan Flinn |
|
Providence-based EpiVax Inc. was awarded a $55,000 grant from the GBS/CIDP Foundation International to explore using Tregitopes as a new therapy for a nerve disease that is treated currently with intravenous immunoglobulin.
more
By Richard Asinof |
|
(Updated, 5:20 p.m.)
IlluminOss Medical Inc. terminated President and CEO Scott Rader Monday, company founder Robert Rabiner said Wednesday.
more
By Patrick Anderson |
|
Thousand Oaks, Calif.–based Amgen, one of the world’s largest biotechnology companies, saw revenue rise 9.5 percent to $4.3 billion in the three months ended Sept. 30 from $3.9 billion during the same period in 2011.
more
By PBN Staff
|
|
The R.I. Economic Development Corporation approved a corporate tax cut Monday night for Alexion Pharmaceuticals under the state’s Jobs Development Act.
more
By Patrick Anderson |
|
IlluminOss Medical Inc. and G-Form LLC were two of the four companies honored at the Boston Museum of Science’s second annual “Invented Here” awards.
more
By PBN Staff
|
|
During the fiscal year ended June 30, the National Institutes of Health awarded a total of $146.96 million in grants to Rhode Island hospitals, universities and companies.
more
By Emily Greenhalgh |
|
The Norman Prince Neurosciences Institute at Rhode Island Hospital was awarded three philanthropic gifts totaling nearly $600,000 to improve brain science in the state of Rhode Island by supporting research and establishing a lecture series.
more
By Emily Greenhalgh |
